Illumina, Labcorp Expand Partnership to Advance Precision Oncology
Illumina and Labcorp have expanded their collaboration to strengthen precision oncology through wider use of next-generation sequencing (NGS) technologies.
Illumina | 20/03/2026 | By Darshana
Illumina, Labcorp Expand Partnership to Boost Access to Precision Oncology Testing
Illumina and Labcorp deepen collaboration to expand next-generation sequencing-based cancer testing, improve access to biomarker diagnostics, and accelerate development of precision oncology solutions.
Illumina | 19/03/2026 | By News Bureau
Illumina has completed its USD 350 million acquisition of SomaLogic, strengthening its multiomics portfolio and expanding large-scale proteomics capabilities to accelerate drug discovery and improve patient outcomes.
Illumina | 02/02/2026 | By News Bureau | 523
NVIDIA Teams Up with Industry Leaders to Accelerate Genomics and Drug Discovery
Healthcare leaders IQVIA, Illumina and Mayo Clinic, as well as Arc Institute, are using the latest NVIDIA technologies to develop solutions that will help advance human health.
Illumina | 15/01/2025 | By Aishwarya | 464
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy